In Ukraine, a vaccine against chicken hemophilosis was developed

Published 2022년 12월 9일

Tridge summary

Scientists from the Department of Veterinary Medicine of the National Academy of Agrarian Sciences (NAAS) have developed a technological regulation for the production of a vaccine against chicken hemophilosis. The President of the National Academy of Sciences, Yaroslav Gadzalo, announced the development, stating that the domestic vaccine will replace imported ones. Chicken hemophilosis, also known as infectious rhinitis, is an highly infectious disease that can cause significant economic losses. The disease causes subcutaneous swelling of the head and can lead to other diseases like mycoplasmosis, despite having low mortality.

Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Scientists of the Department of Veterinary Medicine of the National Academy of Agrarian Sciences (NAAS) have developed a technological regulation for the production of a vaccine against chicken hemophilosis. This was announced by the President of the National Academy of Sciences, Yaroslav Gadzalo. According to him, domestic development will adequately replace imported analogues. Poultry hemophilosis (infectious rhinitis) is an acute enzootic highly infectious disease of the upper respiratory tract of poultry, primarily chickens and hens, characterized by catarrhal inflammation of the mucous membranes of the nasal cavity, conjunctiva, and sinuses, as well as subcutaneous swelling of the head and, in rare cases, ...

Source: Agrotimes